{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:07:28Z","timestamp":1793142448038,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.critrevonc.2015.11.014","type":"journal-article","created":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T22:32:22Z","timestamp":1448317942000},"page":"325-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"special_numbering":"C","title":["Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review"],"prefix":"10.1016","volume":"98","author":[{"given":"Clo\u00e9","family":"Brami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2015.11.014_bib0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0168-8227(97)00123-X","article-title":"Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study","volume":"39","author":"Abuaisha","year":"1998","journal-title":"Diab. Res. Clin. Pract."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1590\/S1516-31802013000100006","article-title":"Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: a pilot randomized clinical trial","volume":"131","author":"Afonseca","year":"2013","journal-title":"Sao Paulo Med. J."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/aim.25.1-2.11","article-title":"Two styles of acupuncture for treating painful diabetic neuropathy\u2014a pilot randomised control trial","volume":"25","author":"Ahn","year":"2007","journal-title":"Acupunct. Med."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0020","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","article-title":"Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer","volume":"350","author":"Andre","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0025","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s00520-006-0072-3","article-title":"A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results","volume":"14","author":"Argyriou","year":"2006","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpainsymman.2006.03.013","article-title":"Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation","volume":"32","author":"Argyriou","year":"2006","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0035","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/1534735414534729","article-title":"A pilot study of acupuncture in treating bortezomib-induced peripheral neuropathy in patients with multiple myeloma","volume":"13","author":"Bao","year":"2014","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0040","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/0284186X.2014.980912","article-title":"Peripheral neuropathy in colorectal cancer survivors: the influence of oxaliplatin administration. Results from the population-based PROFILES registry","volume":"54","author":"Beijers","year":"2015","journal-title":"Acta Oncol."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00004479-200401000-00007","article-title":"Approaching complementary and alternative medicine use in patients with cancer: questions and challenges","volume":"27","author":"Ben-Arye","year":"2004","journal-title":"J. Ambul. Care Manage."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1023\/A:1006124917643","article-title":"Amelioration of experimental cisplatin and paclitaxel neuropathy with glutamate","volume":"41","author":"Boyle","year":"1999","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.clbc.2011.03.006","article-title":"Peripheral neuropathy with microtubule-targeting agents: occurrence and management approach","volume":"11","author":"Carlson","year":"2011","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0060","article-title":"Chemotherapy-induced peripheral neuropathy: what do we know about mechanisms?","author":"Carozzi","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0065","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/S0959-8049(02)00229-0","article-title":"Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity","volume":"38","author":"Cavaletti","year":"2002","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0070","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejca.2009.12.008","article-title":"Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools","volume":"46","author":"Cavaletti","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0075","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S1470-2045(11)70131-0","article-title":"Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics","volume":"12","author":"Cavaletti","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0080","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1634\/theoncologist.2011-0343","article-title":"Calcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: is it a trade-off between drug efficacy and toxicity","volume":"16","author":"Cavaletti","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0085","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10549-008-0018-1","article-title":"Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients","volume":"114","author":"Chirivella","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0090","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00520-011-1231-8","article-title":"Case report of a patient with chemotherapy-induced peripheral neuropathy treated with manual therapy (massage)","volume":"19","author":"Cunningham","year":"2011","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0095","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrclinonc.2013.125","article-title":"Complementary or alternative medicine in cancer care-myths and realities","volume":"10","author":"Deng","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0100","first-page":"85","article-title":"Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals","volume":"7","author":"Deng","year":"2009","journal-title":"J. Soc. Integr. Oncol."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0105","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.6004\/jnccn.2014.0121","article-title":"Survivorship: healthy lifestyles, version 2.2014","volume":"12","author":"Denlinger","year":"2014","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/bja\/aet208","article-title":"Neuropathic pain in cancer","volume":"111","author":"Fallon","year":"2013","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1756-8722-7-41","article-title":"Electroacupuncture for thalidomide\/bortezomib-induced peripheral neuropathy in multiple myeloma: a feasibility study","volume":"7","author":"Garcia","year":"2014","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0120","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/1471-2407-12-355","article-title":"Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial","volume":"12","author":"Ghoreishi","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0125","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00520-013-2075-1","article-title":"Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial","volume":"22","author":"Guo","year":"2014","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.critrevonc.2014.10.006","article-title":"A review of relative dose intensity and survival in patients with metastatic solid tumors","volume":"93","author":"Havrilesky","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00520-013-1925-1","article-title":"Strength and endurance training in the treatment of lung cancer patients in stages IIIA\/IIIB\/IV","volume":"22","author":"Henke","year":"2014","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0140","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1200\/JCO.2012.44.8738","article-title":"Randomized double-blind placebo-controlled trial of acetyl-l-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy","volume":"31","author":"Hershman","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0145","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"32","author":"Hershman","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0150","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/1534735411423920","article-title":"How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis","volume":"11","author":"Horneber","year":"2012","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0155","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3892\/etm.2011.375","article-title":"Objective evaluation of the alleviating effects of Goshajinkigan on peripheral neuropathy induced by paclitaxel\/carboplatin therapy: a multicenter collaborative study","volume":"3","author":"Kaku","year":"2012","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0160","first-page":"1765","article-title":"(R)-(+)-alpha-lipoic acid protected NG108-15 cells against H(2)O(2)-induced cell death through PI3K-Akt\/GSK-3beta pathway and suppression of NF-kappabeta-cytokines","volume":"8","author":"Kamarudin","year":"2014","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jpainsymman.2007.02.043","article-title":"Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms","volume":"35","author":"Kautio","year":"2008","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0170","first-page":"2601","article-title":"Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms","volume":"29","author":"Kautio","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0175","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1007\/s00520-010-1043-2","article-title":"Burden of chemotherapy-induced neuropathy\u2013a cross-sectional study","volume":"19","author":"Kautio","year":"2011","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0180","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1634\/theoncologist.2011-0157","article-title":"Calcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: is it a trade-off between drug efficacy and toxicity","volume":"16","author":"Khattak","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0185","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/1745-6215-14-254","article-title":"Electroacupuncture for chemotherapy-induced peripheral neuropathy: study protocol for a pilot multicentre randomized, patient-assessor-blinded, controlled trial","volume":"14","author":"Kim","year":"2013","journal-title":"Trials"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0190","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00280-013-2306-7","article-title":"Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, doubleblind, placebocontrolled trial of goshajinkigan to prevent oxaliplatininduced neuropathy","volume":"72","author":"Kono","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0195","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s00520-010-1018-3","article-title":"The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial","volume":"19","author":"Kottschade","year":"2011","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0200","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1200\/JCO.2006.08.6652","article-title":"Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07","volume":"25","author":"Land","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0205","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.3748\/wjg.14.2434","article-title":"Impact of postoperative omega-3 fatty acid-supplemented parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patients","volume":"14","author":"Liang","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0210","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2354.2008.00996.x","article-title":"Long-term glutamate supplementation failed to protect against peripheral neurotoxicity of paclitaxel","volume":"18","author":"Loven","year":"2009","journal-title":"Eur. J. Cancer Care (Engl.)"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0215","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1200\/JCO.2008.20.9189","article-title":"Chronic physical effects and health care utilization in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group study","volume":"27","author":"Matei","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0220","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2174\/157488411798375967","article-title":"Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control","volume":"6","author":"Miranda-Massari","year":"2011","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0225","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1200\/JCO.2013.49.1514","article-title":"Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry","volume":"31","author":"Mols","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0230","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00520-014-2255-7","article-title":"Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review","volume":"22","author":"Mols","year":"2014","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0235","doi-asserted-by":"crossref","DOI":"10.1007\/s11764-015-0427-1","article-title":"Chemotherapy-induced peripheral neuropathy, physical activity and health-related quality of life among colorectal cancer survivors from the PROFILES registry","author":"Mols","year":"2015","journal-title":"J. Cancer Survivorship"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0240","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1001\/jama.280.17.1518","article-title":"Acupuncture","volume":"280","author":"NIH Consensus Conference","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0245","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/09540120600971083","article-title":"Symptom management and self-care for peripheral neuropathy in HIV\/AIDS","volume":"19","author":"Nicholas","year":"2007","journal-title":"AIDS Care"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0250","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s10147-010-0183-1","article-title":"The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen","volume":"16","author":"Nishioka","year":"2011","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0255","first-page":"619","article-title":"Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies","volume":"12","author":"Ocean","year":"2004","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0260","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1212\/WNL.0b013e3181d5279e","article-title":"Vitamin E. neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial","volume":"74","author":"Pace","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0265","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1634\/theoncologist.2010-0248","article-title":"Long-term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility","volume":"16","author":"Park","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0270","doi-asserted-by":"crossref","first-page":"e14433","DOI":"10.1371\/journal.pone.0014433","article-title":"Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials","volume":"5","author":"Phillips","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0275","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/PL00007853","article-title":"Chemotherapy-induced peripheral neuropathy","volume":"249","author":"Quasthoff","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0280","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1212\/WNL.59.7.1015","article-title":"Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial","volume":"59","author":"Raja","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0285","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/cncr.23008","article-title":"Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3)","volume":"110","author":"Rao","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0290","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jpainsymman.2009.09.020","article-title":"Neuropathic pain in breast cancer survivors: using the ID pain as a screening tool","volume":"39","author":"Reyes-Gibby","year":"2010","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0295","doi-asserted-by":"crossref","first-page":"349653","DOI":"10.1155\/2013\/349653","article-title":"Chemotherapy-induced peripheral neuropathy in cancer patients: a four-arm randomized trial on the effectiveness of electroacupuncture","volume":"2013","author":"Rostock","year":"2013","journal-title":"Evid.-Based Complement. Altern. Med.: eCAM"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0300","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0305-7372(03)00133-6","article-title":"Prevention of chemotherapy and radiation toxicity with glutamine","volume":"29","author":"Savarese","year":"2003","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0305","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/acupmed-2011-010034","article-title":"Acupuncture for chemotherapy-induced peripheral neuropathy (CIPN): a pilot study using neurography","volume":"30","author":"Schroeder","year":"2012","journal-title":"Acupunct. Med."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0310","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0315","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.febslet.2008.04.021","article-title":"Alpha-lipoic acid induces apoptosis in hepatoma cells via the PTEN\/Akt pathway","volume":"582","author":"Shi","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0320","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1001\/jama.280.18.1590","article-title":"Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS","volume":"280","author":"Shlay","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0325","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/diacare.28.1.89","article-title":"Acetyl-l-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials","volume":"28","author":"Sima","year":"2005","journal-title":"Diab. Care"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0330","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10495-006-0487-9","article-title":"generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells","volume":"12","author":"Simbula","year":"2007","journal-title":"Apoptosis."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0335","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","article-title":"Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial","volume":"309","author":"Smith","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0340","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0707056","article-title":"Weekly paclitaxel in the adjuvant treatment of breast cancer","volume":"358","author":"Sparano","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0345","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s00520-011-1365-8","article-title":"Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients","volume":"20","author":"Speck","year":"2012","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0350","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1200\/JOP.2012.000863","article-title":"Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in nonmetastatic breast cancer","volume":"9","author":"Speck","year":"2013","journal-title":"J. Oncol. Pract."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0355","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/IGC.0b013e31819902ec","article-title":"Physical activity in ovarian cancer survivors: associations with fatigue, sleep, and psychosocial functioning","volume":"19","author":"Stevinson","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0360","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/annonc\/mdt568","article-title":"Exercise program improves therapy-related side-effects and quality of life in lymphoma patients undergoing therapy","volume":"25","author":"Streckmann","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0365","first-page":"455","article-title":"Neuropathy associated with microtubule inhibitors: diagnosis, incidence, and management","volume":"6","author":"Swain","year":"2008","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0370","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(03)12468-3","article-title":"Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial","volume":"361","author":"Thies","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0375","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1634\/theoncologist.12-3-312","article-title":"Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients","volume":"12","author":"Wang","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0380","doi-asserted-by":"crossref","first-page":"128726","DOI":"10.1155\/2014\/128726","article-title":"Long-term effects of goshajinkigan in prevention of diabetic complications: a randomized open-labeled clinical trial","volume":"2014","author":"Watanabe","year":"2014","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2015.11.014_bib0385","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1079\/BJN2001461","article-title":"Immunomodulation by perioperative administration of n-3 fatty acids","volume":"87","author":"Weiss","year":"2002","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0390","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1529-8027.2008.00156.x","article-title":"Chemotherapy-induced neuropathy","volume":"13","author":"Windebank","year":"2008","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2015.11.014_bib0395","first-page":"45","article-title":"Acetyl-l-carnitine in HIV-associated antiretroviral toxic neuropathy","volume":"21","author":"Youle","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0400","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pneurobio.2008.05.004","article-title":"Neural mechanism underlying acupuncture analgesia","volume":"85","author":"Zhao","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.critrevonc.2015.11.014_bib0405","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1464-5491.2004.01109.x","article-title":"Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis","volume":"21","author":"Ziegler","year":"2004","journal-title":"Diabet. Med."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842815300822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842815300822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T14:03:43Z","timestamp":1638713023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842815300822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":81,"alternative-id":["S1040842815300822"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2015.11.014","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2015.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}